Pacific Edge looks to US comeback after $19.1m half-year loss

Pacific Edge looks to US comeback after $19.1m half-year loss
Pacific Edge chief executive Peter Meintjes. (Image: Pacific Edge)
Greg Hurrell
Pacific Edge has posted a net loss of $19.1 million for the six months to Sept 30, 2025, as its recent loss of US Medicare coverage chokes back revenue. However, the Dunedin-based medical tech company says it is now very confident of winning back Medicare coverage for its suite of non-invasive bladder cancer tests. The Cxbladder tests, including Triage and the next-generation Triage Plus, are used to detect cancer by analysing a urine sample for specific genetic markers.In its unaudited results, total revenue for the first half of the...

More Markets

Property stocks outshine NZX 50 so far in 2025
Finance

Property stocks outshine NZX 50 so far in 2025

But the sector takes a breather in November as reporting season ends.

Thinking of investing? Skip 'most' of NZX
Opinion

Simon Robertson: Thinking of investing? Skip 'most' of NZX

If you want to grow your wealth, then buy the S&P 500. Period.

Simon Robertson 06 Dec 2025
Fisher and Paykel Healthcare drives NZ stocks to weaker finish
Markets Market Close

Fisher and Paykel Healthcare drives NZ stocks to weaker finish

The S&P/NZX 50 Index closed down 31.63 points, or 0.23%, to 13,483.99.

Jamie Gray 05 Dec 2025
Fletcher Building extends bank covenant deal
Markets

Fletcher Building extends bank covenant deal

The company cannot pay a dividend until it meets its standard covenant levels.

Rebecca Howard 05 Dec 2025